Crystalline form IV of linezolid
    1.
    发明申请
    Crystalline form IV of linezolid 审中-公开
    利奈唑胺的结晶形式IV

    公开(公告)号:US20080319191A1

    公开(公告)日:2008-12-25

    申请号:US12229402

    申请日:2008-08-22

    IPC分类号: C07D413/02

    CPC分类号: A61K31/535 C07D263/20

    摘要: The present invention provides a novel crystalline form of linezolid referred to herein as Form IV as well as methods for the preparation and use of Form IV. The present invention provides pharmaceutical compositions that comprise therapeutically effective amounts of Form IV that can be used to treat patients suffering from gram-positive bacterial infections. Various processes for making crystalline linezolid Form IV are disclosed.

    摘要翻译: 本发明提供了本文称为形式IV的利奈唑胺的新型结晶形式以及制备和使用形式IV的方法。 本发明提供包含治疗有效量的形式IV的药物组合物,其可用于治疗患有革兰氏阳性细菌感染的患者。 公开了制备结晶利奈唑胺形式IV的各种方法。

    Reference for characterization of rosuvastatin
    3.
    发明申请
    Reference for characterization of rosuvastatin 有权
    罗苏伐他汀的表征参考

    公开(公告)号:US20070249831A1

    公开(公告)日:2007-10-25

    申请号:US11823045

    申请日:2007-06-25

    申请人: Nina Finkelstein

    发明人: Nina Finkelstein

    IPC分类号: C07D239/70

    CPC分类号: C07D239/70

    摘要: Provided are rosuvastatin degradation products and their use as a reference standard (including reference marker) for analysis of rosuvastatin.

    摘要翻译: 提供罗苏伐他汀降解产物及其作为参考标准(包括参考标记)用于分析罗苏伐他汀的用途。